Tamsulosin (0.4 mg/j)
Sponsors
Assistance Publique - Hôpitaux de Paris, Berlin-Chemie AG Menarini Group
Conditions
Healthy Adult Males VolunteersHealthy Volunteer Male SubjectsHealthy VolunteersMaleUrinary Retention
Phase 1
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions
Active, not recruitingNCT07091669
Start: 2025-06-16End: 2025-11-22Target: 46Updated: 2025-08-08
A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State
Active, not recruitingNCT07146711
Start: 2025-03-03End: 2025-12-01Updated: 2025-08-28
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions
RecruitingNCT07156916
Start: 2025-09-08End: 2026-05-01Target: 46Updated: 2025-10-03